Novo Nordisk’s $1.1 Billion Acquisition of Forma Therapeutics

Davis Polk advised Novo Nordisk on the deal while Goodwin Procter represented Forma Therapeutics.Novo Nordisk announced its approximately $1.1 billion acquisition of Forma Therapeutics. Under the terms…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Laura Testa

Author: Laura Testa

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here